Viewing Study NCT00802906


Ignite Creation Date: 2025-12-26 @ 10:59 AM
Ignite Modification Date: 2026-06-03 @ 12:34 AM
Study NCT ID: NCT00802906
Status: COMPLETED
Last Update Posted: 2012-09-27
First Post: 2008-12-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)
Sponsor: Johann Wolfgang Goethe University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Central Serous Chorioretinopathy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None micropulselaserphotocoagulation View
None bevacizumab View
None CSC View